Union Square Park Capital Management »

Soleno Therapeutics shares owned by Union Square Park Capital Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Union Square Park Capital Management from 13F filings

Historical chart of Union Square Park Capital Management investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Union Square Park Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Union Square Park Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.4M 65k 83.78
2024-12-31 $2.2M 50k 44.95

More positions owned by Union Square Park Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Lyft Cl A Com (LYFT)
Peloton Interactive Cl A Com Call Option (PTON)
Compass Cl A Call Option (COMP)
Rh (RH)
Paypal Holdings Call Option (PYPL)
Caesars Entertainment (CZR)
Ridenow Group Com Cl B (RDNW)
Establishment Labs Holdings Ord (ESTA)
Forward Air Corp (FWRD)
Industrial Logistics Pptys T Com Shs Ben Int (ILPT)
UnitedHealth (UNH)
Mohawk Industries (MHK)

View all positions for Union Square Park Capital Management

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vivo Capital
State Street Corporation
Invesco
Caption Management
Adage Capital Partners GP
Commodore Capital
Braidwell
Millennium Management
Polar Capital Holdings

View all funds holding Soleno Therapeutics